|
Aug 5
|
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Jul 31
|
New Strong Sell Stocks for July 31st
|
|
Jul 30
|
Grifols tops earnings, revenue estimates despite foreign-exchange headwinds
|
|
Jul 28
|
Sector Update: Health Care Stocks Softer Monday Afternoon
|
|
Jul 28
|
Astrazeneca, Other US-Listed Pharma Companies Seen Insulated From New EU Tariff Deal, Barclays Says
|
|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
|
Jul 17
|
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
|
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
|
Jun 16
|
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
|
|
Jun 5
|
Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know
|
|
Jun 3
|
Is Grifols (GRFS) Stock Undervalued Right Now?
|
|
Jun 2
|
GRFS vs. STVN: Which Stock Is the Better Value Option?
|
|
May 30
|
US court proceeds with Grifols defamation case against Gotham City, but narrows scope
|
|
May 28
|
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?
|
|
May 22
|
FDA clears Grifols’ application for dry eye disease treatment
|